| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_67dd1f39f37bac4617e37d6d5c60aa8b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D265-30 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 |
| filingDate |
2014-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bf375acfabde499596856386b47f0d8 |
| publicationDate |
2019-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-I679978-B |
| titleOfInvention |
Ophthalmic disease treatment |
| abstract |
The present invention provides a morpholine compound represented by the general formula (1) or a pharmaceutically acceptable salt thereof as an active ingredient, as a therapeutic or preventive agent for ophthalmic diseases caused by ocular angiogenesis.nn n n [Wherein ring A represents an aryl group and the like which may have a substituent; ring B represents an aryl group and the like which may have a substituent; m = 0 to 2; n = 1 to 5; X represents a bond, etc .; Y represents a bond Knot, etc .; Z represents a hydrogen atom, etc. ] |
| priorityDate |
2013-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |